Cargando…
Mechanisms of Chemotherapy-Induced Neurotoxicity
Since the first clinical trials conducted after World War II, chemotherapeutic drugs have been extensively used in the clinic as the main cancer treatment either alone or as an adjuvant therapy before and after surgery. Although the use of chemotherapeutic drugs improved the survival of cancer patie...
Autores principales: | Was, Halina, Borkowska, Agata, Bagues, Ana, Tu, Longlong, Liu, Julia Y. H., Lu, Zengbing, Rudd, John A., Nurgali, Kulmira, Abalo, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996259/ https://www.ncbi.nlm.nih.gov/pubmed/35418856 http://dx.doi.org/10.3389/fphar.2022.750507 |
Ejemplares similares
-
Editorial: Cancer therapy: The challenge of handling a double-edged sword
por: Nurgali, Kulmira, et al.
Publicado: (2022) -
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
por: Nurgali, Kulmira, et al.
Publicado: (2018) -
Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments
por: McQuade, Rachel M., et al.
Publicado: (2016) -
Insights Into Acute and Delayed Cisplatin-Induced Emesis From a Microelectrode Array, Radiotelemetry and Whole-Body Plethysmography Study of Suncus murinus (House Musk Shrew)
por: Tu, Longlong, et al.
Publicado: (2021) -
Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT(3) Antagonist, Palonosetron and With the NK(1) Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)
por: Rudd, John A., et al.
Publicado: (2018)